Skip to main content
Premium Trial:

Request an Annual Quote

New England Biolabs to Distribute Rubicon Amplification Tech in Kit

NEW YORK (GenomeWeb News) – New England Biolabs will distribute Rubicon Genomics' amplification technology as part of a kit being sold for single-cell amplification, the firms announced today.

Ipswich, Mass.-based New England Biolabs will offer the Single Cell Whole Genome Amplification Kit, which will include the Rubicon technology that enables the amplification of DNA from single cells or extremely low amounts of input DNA. New England Biolabs said that the kit is its first product aimed at the single-cell amplification market.

"This single cell amplification technology has already been widely adopted in the in vitro fertilization (IVF) market, and we are excited at the prospects this product has in research applications," Jim Koziarz, president and CEO of Rubicon, said in a statement.

Terms of the agreement were not disclosed.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more